about
sameAs
RNA interference: biology, mechanism, and applicationsRibozyme-mediated REV1 inhibition reduces the frequency of UV-induced mutations in the human HPRT genePredicting candidate genomic sequences that correspond to synthetic functional RNA motifs.Isolation of specific and high-affinity RNA aptamers against NS3 helicase domain of hepatitis C virus.Supercritical carbon dioxide design strategies: from drug carriers to soft killersDifferential cytokine activity and morphology during wound healing in the neonatal and adult rat skinThe diversity of mtDNA rns introns among strains of Ophiostoma piliferum, Ophiostoma pluriannulatum and related speciesAdhesion through single peptide aptamers.Functional nucleic acid sensorsYeast genetic selections to optimize RNA decoys for transcription factor NF-kappa BNew high-technology products for the treatment of haemophilia.Combining SELEX and the yeast three-hybrid system for in vivo selection and classification of RNA aptamersMammalian cell transfection: the present and the future.Extensive exon reshuffling over evolutionary time coupled to trans-splicing in Drosophila.Trans-splicing into highly abundant albumin transcripts for production of therapeutic proteins in vivo.Novel approaches towards conquering hepatitis B virus infection.TLR9-mediated siRNA delivery for targeting of normal and malignant human hematopoietic cells in vivo5' exon replacement and repair by spliceosome-mediated RNA trans-splicingImaging Tetrahymena ribozyme splicing activity in single live mammalian cells.Solution structure of an informationally complex high-affinity RNA aptamer to GTPEvidence for recycling of external guide sequences during cleavage of bipartite substrates in vitro by reconstituted archaeal RNase P.High-efficiency transfection of primary human and mouse T lymphocytes using RNA electroporationPluripotent state induction in mouse embryonic fibroblast using mRNAs of reprogramming factorsFluorescence and solution NMR study of the active site of a 160-kDa group II intron ribozyme.Ribozyme therapy: RNA enzymes to the rescue.Messenger RNA reprogramming by spliceosome-mediated RNA trans-splicingSingle-molecule transition-state analysis of RNA folding.Nucleic acid aptamers as tools and drugs: recent developments.Engineered ribozymes as molecular tools for site-specific alteration of RNA sequence.Messenger RNA-based vaccines.Expansion of HIV-specific CD4+ and CD8+ T cells by dendritic cells transfected with mRNA encoding cytoplasm- or lysosome-targeted NefNatural and engineered nucleic acids as tools to explore biology.Porphyrin-related photosensitizers for cancer imaging and therapeutic applications.Maxizyme-mediated specific inhibition on mutant-type p53 in vitro.Recent advances in immunotherapy of B-CLL using ex vivo modified dendritic cells.Antigen-specific cellular immunotherapy of leukemia.Improving pharmacotherapy outcomes by pharmacogenomics: from expectation to reality?Aptamer-based SERRS sensor for thrombin detection.Potential applications of RNA interference technology in the treatment of cancer.The Cech Symposium: a celebration of 25 years of ribozymes, 10 years of TERT, and 60 years of Tom.
P2860
Q24597695-ED50ACFF-844E-4A4E-A5E0-CABEF3DE2CD4Q24685084-60610488-A693-4EE7-8D5E-5B8B53A1E350Q24811092-03CBF044-AC1E-4D94-ABFA-BF8017E20756Q27472976-9E759E6A-9E85-405D-9963-B1B70D797E7BQ28085090-1BF72DE8-DF34-432D-867F-ED85997DB9F2Q28570786-5B0371FE-8299-40EA-9CA8-75CA78F7E448Q28829299-E89C1E05-D965-40C1-9B66-42225FB2A3E7Q30437104-B20301E4-CB15-4DE3-8B9F-37677C1196BAQ30481633-E12CBC75-DE39-4C78-9C0C-272F5246B02CQ30897995-FC078FF6-F647-493E-A5DD-75FF24145935Q31120359-4C4C5CF5-9CCF-49F0-814B-7C924D76ED97Q33272405-F74E3616-3D20-463E-8E10-8CF076EC1442Q33605046-A8A8F0F4-3875-4E0B-8474-EF0847388AC5Q33678762-B92C375A-27CA-42EC-AF51-41B101465A55Q33713295-A95441AE-90BE-4315-A104-ED07C4479A35Q33787687-EC225B2C-BEB9-4E27-8BF7-18A38C887BDFQ34320769-3BED6B7F-344C-4FA7-894F-007E78EFF731Q34365389-771F86C3-3D50-4AAD-A27C-DC19FB0476E2Q34387772-5A0166C3-DBB8-47CD-AFC8-63A9738206AFQ34498130-68E52756-9B71-41A0-9165-6FA943423153Q34514874-C057C112-C175-4EC4-957C-BFB79319D3C4Q34657652-249E5148-7269-4608-85BA-0A1A7FF315E2Q34833754-AE1EC793-80EC-4B4F-A8C7-E31E7AAB490BQ35012694-4CBBA4A9-F30A-4A9C-8048-FE0A9F06F90CQ35144547-3B4DBBF5-9FFF-44CA-9BE4-EBE6ADA384AEQ35202462-B1B16696-46D5-4AEF-9118-99383BB13045Q35234470-EFE1A01A-5DB5-44E1-8924-57BB9E3D0236Q35549348-C666E187-0658-4FF4-A37A-A84556801DA9Q35549357-1942D460-6C01-4878-B1F9-D3A39D1A63DBQ35842616-3C6E2567-97A0-4188-9E37-04E57026D746Q35849445-A870FC4A-CB7E-4B8F-A9FE-874FB71A1F5AQ35986039-5565800E-B62C-4D0B-BE0C-4131E0264BBBQ36109127-73C7D03C-84B2-4729-841D-6EE8A57C4EBAQ36190740-1426594F-40BA-4530-8DA0-40ABE4477B67Q36194575-25A1ED7F-1BEB-49B2-BA52-974719B9642CQ36240201-0A1BFBC2-303E-458C-8D1D-D198ABC8266EQ36278015-2AB820E2-817E-4843-902B-29EAE8FE5A80Q36336950-7DB0FC9E-C3B7-4B22-BC49-84A7FB5946BAQ36429400-0DD6B93C-CE59-4A6A-8EA0-8AEBC795F11FQ36470329-3C6E70D1-2724-4754-9B29-0C0DCCCD32FD
P2860
description
2002 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
article publié dans la revue scientifique Nature
@fr
artículu científicu espublizáu en 2002
@ast
scientific article (publication date: 11 July 2002)
@en
vedecký článok (publikovaný 2002/07/11)
@sk
vědecký článek publikovaný v roce 2002
@cs
wetenschappelijk artikel (gepubliceerd op 2002/07/11)
@nl
наукова стаття, опублікована в липні 2002
@uk
مقالة علمية (نشرت في 11-7-2002)
@ar
name
Emerging clinical applications of RNA
@ast
Emerging clinical applications of RNA
@en
Emerging clinical applications of RNA
@nl
type
label
Emerging clinical applications of RNA
@ast
Emerging clinical applications of RNA
@en
Emerging clinical applications of RNA
@nl
prefLabel
Emerging clinical applications of RNA
@ast
Emerging clinical applications of RNA
@en
Emerging clinical applications of RNA
@nl
P2860
P3181
P356
P1433
P1476
Emerging clinical applications of RNA
@en
P2093
Bruce A Sullenger
Eli Gilboa
P2860
P2888
P3181
P356
10.1038/418252A
P407
P577
2002-07-11T00:00:00Z
P5875
P6179
1010431757